- Home
- ABEO vs OB Comparison
ABEO vs OB Comparison
Compare ABEO & OB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- OB
- Stock Information
- Founded
- ABEO N/A
- OB 2006
- Country
- ABEO United States
- OB United States
- Employees
- ABEO N/A
- OB N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- OB Industrial Machinery/Components
- Sector
- ABEO Health Care
- OB Industrials
- Exchange
- ABEO Nasdaq
- OB Nasdaq
- Market Cap
- ABEO 243.9M
- OB 251.0M
- IPO Year
- ABEO 1980
- OB 2021
- Fundamental
- Price
- ABEO $6.46
- OB $4.63
- Analyst Decision
- ABEO Strong Buy
- OB Buy
- Analyst Count
- ABEO 3
- OB 5
- Target Price
- ABEO $18.00
- OB $5.50
- AVG Volume (30 Days)
- ABEO 248.5K
- OB 97.3K
- Earning Date
- ABEO 11-11-2024
- OB 11-05-2024
- Dividend Yield
- ABEO N/A
- OB N/A
- EPS Growth
- ABEO N/A
- OB N/A
- EPS
- ABEO N/A
- OB N/A
- Revenue
- ABEO N/A
- OB $909,356,000.00
- Revenue This Year
- ABEO N/A
- OB $1.92
- Revenue Next Year
- ABEO $7,097.06
- OB $8.20
- P/E Ratio
- ABEO N/A
- OB N/A
- Revenue Growth
- ABEO 147.52
- OB N/A
- 52 Week Low
- ABEO $3.05
- OB $3.34
- 52 Week High
- ABEO $9.01
- OB $5.30
- Technical
- Relative Strength Index (RSI)
- ABEO 67.25
- OB 43.21
- Support Level
- ABEO $6.06
- OB $4.63
- Resistance Level
- ABEO $6.48
- OB $4.83
- Average True Range (ATR)
- ABEO 0.33
- OB 0.14
- MACD
- ABEO 0.05
- OB -0.00
- Stochastic Oscillator
- ABEO 88.98
- OB 44.27
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.